RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY

Clinical trial NCT04937530 · UNKNOWN

Trial details

NCT number: NCT04937530
Sponsor: Biojiva LLC
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Progressive Supranuclear Palsy

Start date: 2021-06-23
Primary completion: 2022-07-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.